under fierce competition by commensal strains of E. coli.
These findings suggest that EHEC may have evolved mechanisms to avoid expending energy to transport and utilize a nutrient that is actively being used by other microbes, possibly giving EHEC a competitive advantage over the microbiota. The fusKR genes, while present in the EHEC O157:H7 serotype, are notably absent in all other published genomes of E. coli. It remains to be seen whether repression of fucose utilization by the FusKR response regulator confers a growth advantage upon EHEC because it can utilize alternative unique carbon sources while commensal strains of E. coli cannot, but it would be telling if transfer of the cognate FusKR pair to commensal strains of E. coli conferred a growth disadvantage to them in the host. This would raise the mirror question: if EHEC uses the FusKR two-component system to abstain from a carbon source that other microbiota members use while in the gastrointestinal tract, has EHEC gained specific mechanisms to utilize unique carbon sources that do not exist in commensal microbiota members?
The [1] . Transgenic expression of YAP in the liver induces uniform expansion of liver mass, whereas prolonged expression of YAP results in tumorigenesis [3] . These combined data demonstrate that the Hippo pathway is a growth-suppressive pathway in both flies and mammals, and that the downstream effector Yki/YAP is a highly potent oncogene.
Several recent studies have addressed roles of the Hippo signaling pathway in self-renewal and repair of the intestinal epithelium. YAP protein is expressed at the bottom of crypts -the stem cell compartments of the intestinal epithelium [4] . Genetic inhibition of Hippo signaling results in hyperplasia of the gut epithelium in both Drosophila and mouse [5] [6] [7] . Consistently, activation of YAP in the intestine results in expansion of undifferentiated progenitor cells [4] . On the other hand, YAP appears to be dispensable in normal intestinal homeostasis since loss of intestinal YAP leads to no visible defects [6] . To study the potential regulatory role of the Hippo signaling pathway in intestinal regeneration, Cai et al. [6] performed a mouse study in the dextran sodium sulfate (DSS)-colitis model. YAP protein expression was elevated two days after DSS-induced damage in regenerating colonic crypts. When YAP was deleted, the repair of DSS-induced intestinal damage was severely impaired. All of these data are consistent with a model in which YAP serves as a growth-promoting protein in the process of intestinal regeneration.
A new study, published recently in Nature [8] , has now revealed an unexpected role of YAP in intestinal regeneration. Barry et al. [8] re-assessed the function of YAP in the mouse intestine. In contrast to the previously reported expansion of undifferentiated crypt progenitors upon ubiquitous expression of YAP, coincident with the nuclear accumulation of the Wnt effector b-catenin [4] , Barry et al. [8] noted that the Wnt signaling pathway was inhibited and that intestinal stem cell markers were reduced upon overexpression of YAP protein specifically in the intestine. As a consequence, proliferative crypts were lost.
The major discrepancy between the two studies could possibly be explained by data collection at different time points. Doxycycline-induced YAP expression in the Cai et al. study [6] was maintained for up to 4.5 days and then followed by doxycycline withdrawal to analyze reversibility of the phenotype. In the latter study by Barry et al. [8] , the degenerative crypt phenotype was first observed at day 7 and was accompanied by complete loss of Paneth cells, which are intermingled with stem cells at crypt bottoms. The data suggest that YAP overexpression inhibits the intestinal differentiation program, which eventually causes the Paneth cell loss. Of note, Paneth cells are a crucial component of the intestinal stem-cell niche [9] . Thus, YAP overexpression in the intestine temporarily suppresses differentiation in agreement with its 'generic' growth-promoting effect. Prolonged expression of YAP will eventually lead to loss of the niche and -paradoxically -thus cause progressive crypt degeneration.
Another set of surprising data from the study by Barry et al. [8] implies that YAP deletion can result in opposite phenotypes in different tissue-regenerative models. Barry et al. [8] confirmed the previous finding that YAP-deficient mice show an impaired regenerative response after DSS-induced tissue damage [6] .
Upon whole-body irradiation, however, YAP-deficient mice demonstrated crypt hyperplasia and overgrowth in both small intestine and colon [8] . The authors confirmed the growth-suppressive function of YAP by stimulation with the Wnt agonist R-spondin1 (Rspo1) [10, 11] , a potent growth factor for intestinal crypts [12] . Loss of YAP increased Wnt/Rspo1 hypersensitivity and induced massive hyperplasia, which was accompanied by upregulation of Wnt targets and intestinal stem cell markers [8] . Together, the data suggest opposite roles for YAP: in one role, YAP serves as an oncoprotein, promoting growth upon DSS-induced intestinal damage; and in the other role, YAP is a growth-repressive protein that restricts Wnt/Rspo1-induced intestinal stem-cell expansion and regeneration after irradiation-induced injury.
To better understand the distinct roles of YAP in tissue regeneration, it is important to distinguish the mechanistic differences between DSS-and irradiation-induced injury models. Oral administration of DSS disrupts mucin production by the intestinal mucosa and induces an inflammatory response, resulting in colitis-like lesions. It has been reported that DSS-induced intestinal epithelial regeneration requires activation of the Notch signaling pathway [13] . Treatment with DSS upregulates expression of the Notch target gene Hes1, whereas inhibition of Notch activation using a gamma-secretase inhibitor impairs DSS-induced intestinal regeneration [13] . Interestingly, YAP overexpression has been shown to induce the expansion of Hes1-expressing crypt progenitor cells, which in turn can be suppressed by gamma-secretase inhibitors [4] . Consistently, knockdown of YAP strongly decreases the abundance of the Notch intracellular domain and of Hes1 expression [7] . Taken together, DSS treatment may activate Notch [8, 14] . For a better understanding of the role of YAP in colon cancer, it will be crucial to unravel the (likely opposing) direct and indirect effects of YAP on crypt stem cells and their niches. Crosstalk of the Hippo pathway with other signaling pathways in homeostatic control of crypts has been proposed. For example, TAZ and YAP have been reported to suppress the Wnt/b-catenin pathway through direct binding to Dishevelled [8, 15] or b-catenin [16] . Further, Mst1/2 and YAP may regulate the Notch pathway through controlling expression of the Notch intracellular domain and Hes1 (see also above) [4, 7] . Finally, YAP may activate the phosphatidylinositol 3-kinase and mTOR signaling pathways through suppression of the PTEN phosphatase [17] . However this story may unravel, the Hippo pathway is taking center stage as a key regulator of organ-size control, tissue regeneration and tumorigenesis. Two new fossil jawbones from Kenya are claimed to confirm a diversity of early Homo species. However, archaic species concepts and an inadequate fossil record continue to obscure the origins of our genus.
Tim White
Human bones are common in cemeteries, but remains of our more ancient ancestors and relatives are fewer, further between and notoriously difficult to recover. This is particularly true for fossils that are millions of years
